A Study of XZP-3621 in Chinese Patients With ALK Positive NSCLC
Clinical trial NCT05482087 · UNKNOWN
Trial details
- NCT number
- NCT05482087
- Sponsor
- Xuanzhu Biopharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2025-05-07
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.